Technology | October 21, 2008

Risk of Contrast Agent Usage Can be Assessed with Piccolo Xpress

The Piccolo Xpress enables cardiologists to quickly run CLIA waived Creatinine and BUN tests via the convenient Kidney Check panel to assess renal function prior to administering contrast agents for a cardiac MRI or CT scans. The injection of these gadolinium or iodine-based contrast agents may put patients at risk for such things as contrast-induced nephropathy (CIN), acute renal failure or nephrogenic systemic fibrosis (NSF), and the Piccolo helps avert these risks. The portable Piccolo Xpress provides lab results in less than 12 minutes with the precision and accuracy comparable to the reference laboratory – without having to conform to moderately complex CLIA lab requirements.

With a POC chemistry analyzer, specialists can run lab tests while the patient is on-site and avoid rescheduled or cancelled appointments for imaging tests and/or treatments due to insufficient labs. This eliminates unnecessary delays in implementing treatment regimens and allows for real-time adjustments to medication therapies which can prove to be vitally important for patients that are especially at-risk. In addition, real-time POC chemistry capabilities can help cardiologists make immediate and better informed treatment decisions during echocardiograms and stress tests

The Piccolo Xpress gives cardiologists an easy and convenient way to closely monitor their patients’ renal function, lipids, liver function and electrolyte levels – critical information needed to quickly address any changes in the patient's condition and adjust medications in real-time. In addition to helping improve patient care, the ability to perform versatile, CLIA waived chemistry screenings at the point-of-care helps cardiologists maximize practice efficiencies and helps sustain profitability.

October 2008

Overlay Init